-
1,500 people set to receive skin cancer treatment that reduces the risk of it returning and spreading
Around 1,500 people aged 12 years and over with melanoma are set to benefit from pembrolizumab (also called Keytruda and made by MSD), a drug that reduces the chance of it returning, following final draft NICE guidance published today (23 September 2022).
-
NICE recommends transplant with good bacteria taken from poo to resolve recurrent Clostridium difficile infections
Experts estimate that 450 to 500 people could be treated using FMT for multiple recurrences of C. diff infections each year.
-
NICE publishes first draft guidance from its Early Value Assessment pilot project recommending smartphone-linked ECG device
It is the first recommendation to be issued by NICE’s diagnostics advisory committee via its Early Value Assessment pilot project.
-
NICE recommends Piqray and Trodelvy, maintaining 100% approvals of breast cancer drugs since 2018
An agreement with the companies on the price of 2 breast cancer treatments, Piqray and Trodelvy, has paved the way for NICE to be able to make them available immediately to around 3,450 people on the NHS and maintaining NICE’s 100% approval rate of breast cancer drugs since 2018.
-
NICE recommends step-change targeted treatment for people with early breast cancer
Around 4,000 people are set to benefit from a step-change in treatment for early breast cancer following today’s (17 June 2022) provisional approval by NICE of abemaciclib in combination with hormone therapy as an option after surgery.
-
New treatment to increase the chances of a successful kidney transplant recommended by NICE
A new treatment that increases the chance of a successful kidney transplant has been recommended by NICE in final draft guidance today (16 June 2022).
-
Hundreds of thousands set to benefit as NICE final draft guidance recommends new treatment to prevent heart attacks and strokes in people with raised blood fats
NICE has today (10 June 2022) published final draft guidance which recommends icosapent ethyl for reducing the risk of cardiovascular events such as heart attacks and strokes in adults who have raised levels of a type of blood fat called triglycerides.
-
NICE recommends potentially life-changing treatment for people with short bowel syndrome
A potentially life-changing treatment has been recommended for people with short bowel syndrome who are aged 1 year and above after NICE published final draft guidance today (01 June 2022)
-
NICE sets out further details on menopause guideline update
NICE has outlined what aspects of menopause care will be updated in upcoming guidance, including areas where more research is needed.